维普中文期刊产品整合服务
21篇 您的检索式:作者名="Poustchi"
    题名 作者 年代 出处 被引量
1Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease显示文摘Nonalcoholic fatty liver disease(NAFLD) is currently known as the most common liver problem, characterized by excessive lipid accumulation in hepatocytes,which may progress to other liver diseases such as nonalcoholic steatohepatitis, hepatic tissue fibrosis, livercirrhosis, and failure or hepatocellular carcinoma. Since NAFLD is positively associated with the development of obesity, insulin resistance, and ultimately type 2 diabetes mellitus, it is often regarded as the hepatic manifestation of the metabolic syndrome. No pharmacologic treatment has yet been proven for this disease. For most patients with presumed or confirmed NAFLD, the only proven strategy is to offer lifestyle advice that can lead to sustained weight loss. Since insulin resistance, oxidative stress, inflammation, and necro-apoptosis are involved in NAFLD pathogenesis, it seems that every potential therapeutic agent should target one or some of these pathologic events. There are many well known anti-oxidants, anti-inflammatory, and insulin sensitizer dietary supplements which have shown beneficial effects on NAFLD improvement in animal and human studies. The purpose of this review is to explore the existing evidences on dietary supplements considered to have hepatoprotective properties, and to present some proposed mechanisms by which they may protect against NAFLD.Tannaz Eslamparast Sareh Eghtesad Hossein Poustchi Azita Hekmatdoost 2015World Journal of Hepatology2015,7,2:26
2Egg consumption and risk of non-alcoholic fatty liver disease显示文摘AIM To evaluate the association between egg consumption and risk of non-alcoholic fatty liver disease(NAFLD) development.METHODS This case-control study was conducted on individuals who were referred to two hepatology clinics in Tehran, Iran in 2015. The study included 169 patients with NAFLD and 782 controls. Egg consumption was estimated using a validated food frequency questionnaire. The participants were categorized according to the frequency of their egg consumption during the previous year: Less than two eggs per week, two to three eggs per week, and four or more eggs per week.RESULTS In the crude model, participants who consumed 2 to 3 eggs per week, were 3.56 times more likely to have NAFLD in comparison to those who consumed less than 2 eggs per week(OR: 3.56; 95%CI: 2.35-5.31). Adjustment for known risk factors of NAFLD strengthenedthis significant association so that individuals have consumed two to three eggs per week had 3.71 times higher risk of NAFLD than those who have eaten less than two eggs per week(OR: 3.71; 95%CI: 1.91, 7.75). CONCLUSION Our data indicate that higher egg consumption in common amount of usage is associated with higher risk of NAFLD.Zeinab Mokhtari Hossein Poustchi Tannaz Eslamparast Azita Hekmatdoost 2017World Journal of Hepatology2017,9,10:3
3Insulin resistance and response to therapy in patients infected with chronic hepatitis C virusgenotypes2 and3 显示文摘Poustchi H Negro F Hui J 2008J Hepatol2008,48,1:1
4Synbiotic supplemen-tation in nonalcoholic fatty liver disease : a randomized, double -blind, placebo - controlled pilot study显示文摘Eslamparast T Poustchi H Zamani F 2014Am J Clin Nutr2014,99,3:1
5The role of mutations in core protein of hepatitis B virus in liver fibrosis 显示文摘Mohamadkhani A Jazii FR Poustchi H 2009J Virol2009,6,:1
6Cardiovascular Disease Mortality and Years of Life Lost Attributable to Non-optimal Systolic Blood Pressure and Hypertension in Northeastern Iran 显示文摘Sepanlou SG Newson RB Poustchi H 2015Arch Iran IVied2015,18,3:1
7The role of mutations in core protein of hepatitis B virus in liver fibrosis显示文摘Mohamadkhani A Jazii F R Poustchi H 2009Virol J2009,26,6:1
8The role of muta- tiongs in core protein of hepatitis B virus in liver fibrosis显示文摘Mohamadkhani A Jazii FR Poustchi H 2009Virol J2009,6,1:1
9Gender differencesin healthy ranges for serum alanine aminotransferaselevels in adolescence显示文摘Poustchi H George J Esmaili S W a/ 2011PLoS One2011,6,21:1
10Fibroscan for assessing liver fibrosis: an acceptable alternative for liver biopsy显示文摘Malekzadeh R Poustchi H 2011Hepat Moil2011,1,3:1
11Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3显示文摘POUSTCHI H NRGRO F HUI J 2008J Hepatol2008,48,1:1
12FibroScan for assessing liver fibro- sis : an acceptable alternative for liver biopsy 显示文摘Malekzadeh R Poustchi H 2011Hepat Mon2011,11,3:1
13Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3显示文摘Hossein Poustchi Francesco Negro Jason Hui Ian Homer Y. Cua Laura Rubbia Brandt James G. Kench Jacob George 2007Journal of Hepatology2007,,1:1
14Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, place- bo-controlled pilot study显示文摘Eslamparast T Poustchi H Zamani F 2014Am J Clin Nutr2014,99,3:1
15Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized,double-blind, placebo-controlled pilot study显示文摘Eslamparast T Poustchi H Zamani F 2014Am J Clin Nutr2014,99,3:1
16Predictors of mental and physical health in non-cirrhotic patients with viral hepatitis: A case control study显示文摘Mandana Ashrafi Amirhossein Modabbernia Mojtaba Dalir Shervin Taslimi Maryam Karami Mohammad Reza Ostovaneh Reza Malekzadeh Hossein Poustchi 2012Journal of Psychosomatic Research2012,,3:1
17Pyloric volume an important factor in the surgeon, ability to palpate the pyloric' Olive in hypertrophic stenosis显示文摘Ozsrath R Poustchi - Am in M Leonidas C 1997Pediatric Radiol1997,27,:1
18Synbiotic supplementationin nonalcoholic fatty liver disease: a randomized, double-blind,placebo-controlled pilot study 显示文摘Eslamparast T Poustchi H Zamani F 2014Am J Clin Nutr2014,99,3:1
19The role of mutations in core protein of hepatitis B virus in liver fibrosis显示文摘Mohamadkhani Ashraf azii Ferdous Poustchi Hossein 2009Virology J2009,6,1:1
20Synbioticsupplementation in nonalcoholic fatty liver disease: a randomized,double - blind,placebo - controlled pilot study显示文摘ESLAMPARAST T POUSTCHI H ZAMANI F 2014Am J Clin Nu-tr2014,99,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费